Aparna Raj Parikh, Michael J. Overman, Christopher T. Chen, Elena Elez, Lucjan Wyrwicz, Chiara Cremolini, Julien Taieb, Ying Yuan, Kei Muro, David Berz, Ming Yin, Karl Albert Eckert, Nindhana Paranthaman, Marwan Fakih. "A randomized, active-controlled phase 3 study of ivonescimab + FOLFOX versus bevacizumab + FOLFOX as first-line treatment of metastatic colorectal cancer (mCRC): HARMONi-GI3.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps3682